Similar Search Results

Out-of-pocket expenditures on health : a global stocktake

Wagstaff, Adam; Eozenou, Patrick; Smitz, Marc - 2019

This paper provides an overview of research on out-of-pocket health expenditures, reviewing the various summary measures and the results of multi-country studies using these measures. The paper presents estimates for 146 countries from all World Bank income groups for all summary measures, along...

Persistent link: https://www.econbiz.de/10012008373

Replication redux : the reproducibility crisis and the case of deworming

Ozier, Owen - 2019

In 2004, a landmark study showed that an inexpensive medication to treat parasitic worms could improve health and school attendance for millions of children in many developing countries. Eleven years later, a headline in the Guardian reported that this treatment, deworming, had been "debunked."...

Persistent link: https://www.econbiz.de/10012022345

Transport connectivity, medical supplies, and people’s health care access : evidence from Madagascar

Iimi, Atsushi; Rajoela, Voahirana Hanitriniala - 2018

Health care access is a challenge in rural areas in Africa. On the demand side, rural people are often poor, and transport connectivity is typically bad in rural and remote areas. Because of limited transport connectivity, the quality of health care services provided is also often compromised....

Persistent link: https://www.econbiz.de/10011875322

Cost Control-Oriented Provisions in Croatian Pharmaceutical Policy

Voncina, Luka - 2018

Croatia operates a mandatory health insurance system with a single public health insurance fund, the Croatian Health Insurance Fund (HZZO), acting as the sole public purchaser of health care services for all insured-the entire population of Croatia. The HZZO holds a monopsony on reimbursement...

Persistent link: https://www.econbiz.de/10012647370

Pricing and Reimbursement Policies in Estonian Pharmaceutical Market

Habicht, Triin - 2018

The case study provides an overview of the main features of the pharmaceuticals pricing andreimbursement policies in …

Persistent link: https://www.econbiz.de/10012647371

Does patient demand contribute to the overuse of prescription drugs?

López, Carolina; Sautmann, Anja; Schaner, Simone - 2020

This study conducted an experiment in Mali to test whether patients pressure doctors to prescribe medical treatment they do not necessarily need. The experiment varied patients' information about a discount for antimalarial tablets and measured demand for both tablets and costlier antimalarial...

Persistent link: https://www.econbiz.de/10012434471

Does Mass Deworming Affect Child Nutrition? Meta-Analysis, Cost-Effectiveness, and Statistical Power

Croke, Kevin - 2016

The WHO has recently debated whether to reaffirm its long-standing recommendation of mass drug administration (MDA) in areas with more than 20 percent prevalence of soil-transmitted helminths (hookworm, whipworm, and roundworm). There is consensus that the relevant deworming drugs are safe and...

Persistent link: https://www.econbiz.de/10012246559

Turkey : Pharmaceutical Sector Analysis

Celik, Yusuf - 2008

Pharmaceuticals are essential to achieve health outcomes, but are at the same time a major cost factor in every health … system. From a patient perspective, access to pharmaceuticals is a proxy for the functioning of the health system. With …; chapter seven gives payment for pharmaceuticals in Turkey; chapter eight presents prescribing practices - rational use of …

Persistent link: https://www.econbiz.de/10012247093

A Generic Drug Policy as Cornerstone to Essential Medicines in China

World Bank - 2010

Compared with developed economies, health expenditure in China is not particularly high on a per capita basis or as a share of Gross Domestic Product (GDP). Similarly, pharmaceutical expenditure in comparative perspective is not particularly high on a per capita basis or as a percentage of GDP....

Persistent link: https://www.econbiz.de/10012247334

Financing, Pricing, and Utilization of Pharmaceuticals in China : The Road to Reform

World Bank - 2010

This paper examines the financing, pricing, and utilization of pharmaceuticals in China the pharmaceutical system as it …

Persistent link: https://www.econbiz.de/10012247481